非手术脑刺激急性治疗成人重性抑郁发作的疗效与可接受性比较:系统综述与网状Meta分析
该系统综述与网状Meta分析检索Embase、PubMed/Medline和PsycINFO至2018年5月8日,纳入113项随机对照试验(262个治疗臂,6750例成人重性抑郁障碍或双相抑郁患者)。网状Meta分析显示,与假刺激相比,10种治疗策略与更高的应答率相关,所有治疗策略的可接受性至少与假刺激相当。结论认为非手术脑刺激技术可考虑作为成人重性抑郁发作的替代或附加治疗。
要点
- 与假刺激相比,10种非手术脑刺激策略与更高的应答相关,其中双颞侧ECT的汇总OR为8.91。
- 所有治疗策略的可接受性至少与假刺激相当。
- 近期治疗手段研究仍不足,需要进一步设计良好的随机对照试验。
核心结论
- 这些发现为非手术脑刺激技术作为成人重性抑郁发作的替代或附加治疗提供了证据。
- 这些发现也凸显了脑刺激领域的重要研究优先事项,如需要进一步设计良好的随机对照试验比较新型治疗,以及研究磁惊厥治疗的假刺激对照试验。
研究设计与样本
- 系统综述与配对及网状Meta分析,检索Embase、PubMed/Medline和PsycINFO至2018年5月8日,并手动检索2009年至2018年发表的若干综述及纳入试验的参考文献。
- 纳入标准为随机分配至电惊厥治疗(ECT)、经颅磁刺激(重复(rTMS)、加速、启动、深部及同步)、θ爆发刺激、磁惊厥治疗、经颅直流电刺激(tDCS)或假刺激治疗的临床试验。
- 共纳入113项试验(262个治疗臂),随机分配6750例重性抑郁障碍或双相抑郁患者(平均年龄47.9岁;59%为女性)。
主要发现
- 网状Meta分析中,与假刺激相比,18种治疗策略中有10种与更高的应答相关:双颞侧ECT(汇总OR 8.91,95%CI 2.57至30.91)、高剂量右侧单侧ECT(7.27,1.90至27.78)、启动经颅磁刺激(6.02,2.21至16.38)、磁惊厥治疗(5.55,1.06至28.99)、双侧rTMS(4.92,2.93至8.25)、双侧θ爆发刺激(4.44,1.47至13.41)、低频右侧rTMS(3.65,2.13至6.24)、间歇性θ爆发刺激(3.20,1.45至7.08)、高频左侧rTMS(3.17,2.29至4.37)和tDCS(2.65,1.55至4.55)。
- 网状Meta分析估计,活性干预与另一活性治疗对比时,双颞侧ECT和高剂量右侧单侧ECT与应答增加相关。
- 所有治疗策略的可接受性至少与假刺激相当。
- 研究最多的治疗比较是高频左侧rTMS和tDCS与假刺激的比较,而近期治疗手段研究仍不足。
- 证据质量通常为低偏倚风险或不明确偏倚风险(113项试验中94项,83%),治疗效应汇总估计的精确度差异很大。
临床怎么用
- 作者认为这些发现为非手术脑刺激技术作为成人重性抑郁发作的替代或附加治疗提供了证据。
局限性
- 近期治疗手段研究仍不足。
- 证据质量通常为低偏倚风险或不明确偏倚风险(113项试验中94项,83%)。
- 治疗效应汇总估计的精确度差异很大。
- 作者指出需要进一步设计良好的随机对照试验比较新型治疗,以及研究磁惊厥治疗的假刺激对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the comparative clinical efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults. DESIGN: Systematic review with pairwise and network meta-analysis. DATA SOURCES: Electronic search of Embase, PubMed/Medline, and PsycINFO up to 8 May 2018, supplemented by manual searches of bibliographies of several reviews (published between 2009 and 2018) and included trials. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Clinical trials with random allocation to electroconvulsive therapy (ECT), transcranial magnetic stimulation (repetitive (rTMS), accelerated, priming, deep, and synchronised), theta burst stimulation, magnetic seizure therapy, transcranial direct current stimulation (tDCS), or sham therapy. MAIN OUTCOME MEASURES: Primary outcomes were response (efficacy) and all cause discontinuation (discontinuation of treatment for any reason) (acceptability), presented as odds ratios with 95% confidence intervals. Remission and continuous depression severity scores after treatment were also examined. RESULTS: 113 trials (262 treatment arms) that randomised 6750 patients (mean age 47.9 years; 59% women) with major depressive disorder or bipolar depression met the inclusion criteria. The most studied treatment comparisons were high frequency left rTMS and tDCS versus sham therapy, whereas recent treatments remain understudied. The quality of the evidence was typically of low or unclear risk of bias (94 out of 113 trials, 83%) and the precision of summary estimates for treatment effect varied considerably. In network meta-analysis, 10 out of 18 treatment strategies were associated with higher response compared with sham therapy: bitemporal ECT (summary odds ratio 8.91, 95% confidence interval 2.57 to 30.91), high dose right unilateral ECT (7.27, 1.90 to 27.78), priming transcranial magnetic stimulation (6.02, 2.21 to 16.38), magnetic seizure therapy (5.55, 1.06 to 28.99), bilateral rTMS (4.92, 2.93 to 8.25), bilateral theta burst stimulation (4.44, 1.47 to 13.41), low frequency right rTMS (3.65, 2.13 to 6.24), intermittent theta burst stimulation (3.20, 1.45 to 7.08), high frequency left rTMS (3.17, 2.29 to 4.37), and tDCS (2.65, 1.55 to 4.55). Network meta-analytic estimates of active interventions contrasted with another active treatment indicated that bitemporal ECT and high dose right unilateral ECT were associated with increased response. All treatment strategies were at least as acceptable as sham therapy. CONCLUSIONS: These findings provide evidence for the consideration of non-surgical brain stimulation techniques as alternative or add-on treatments for adults with major depressive episodes. These findings also highlight important research priorities in the specialty of brain stimulation, such as the need for further well designed randomised controlled trials comparing novel treatments, and sham controlled trials investigating magnetic seizure therapy.
引用
- Mutz J, Vipulananthan V, Carter B, et al. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ. 2019. PMID: 30917990. doi:10.1136/bmj.l1079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。